Skip to main content
. 2008 Nov 20;26(33):5360–5367. doi: 10.1200/JCO.2008.17.4284

Table 3.

Correlation of Imatinib Dose and Tumor Genotype With TTP and OS

Genotype Treatment Arm No. of Patients TTP (months) OS (months)
Exon 11 IM400 141 27.2 60.0
Exon 11 IM800 142 23.9 NR
KIT exon 9 IM400 14 9.4 38.6
KIT exon 9 IM800 18 18.0 38.4
WT IM400 43 15.6 49.0
WT IM800 24 9.8 39.5

Abbreviations: TTP, time to progression; OS, overall survival; IM400, imatinib 400 mg daily; IM800, imatinib 800 mg daily; NR, not reached; WT, wild type.